搜索临床试验以:FLT3-ITD positive Acute Myeloid Leukemia (AML)
总计38385个结果
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC完全的
-
Technische Universität DresdenGerman Federal Ministry of Education and Research; Groupe Francophone des Myelodysplasies; Gruppo... 和其他合作者主动,不招人
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Celgene招聘中
-
The First Affiliated Hospital of Soochow UniversityThe First Affiliated Hospital with Nanjing Medical University; The Affiliated Nanjing Drum Tower... 和其他合作者招聘中
-
King's College LondonKing's College Hospital NHS Trust未知骨髓增生异常综合征 | 白血病,骨髓,急性
-
Astellas Pharma Global Development, Inc.完全的
-
Zhujiang HospitalNanfang Hospital of Southern Medical University; The Third Affiliated Hospital of Southern Medical... 和其他合作者终止
-
Hebei Senlang Biotechnology Inc., Ltd.Hebei Yanda Ludaopei Hospital未知
-
Hospices Civils de Lyon招聘中
-
Ruijin Hospital招聘中
-
University Health Network, Toronto完全的
-
Princess Maxima Center for Pediatric OncologyDaiichi Sankyo招聘中
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; National Institutes of Health (NIH); Medivation, Inc.; The Leukemia...主动,不招人
-
Zhejiang UniversityHangzhou Qihangene Biotech Co.,Ltd.招聘中
-
David Iberri终止成人急性髓系白血病 (AML) 伴多系发育不良继发骨髓增生异常综合征 | 具有 11q23 (MLL) 异常的 AML(成人) | AML(成人)伴 Del (5q) | AML(成人)Inv (16) (p13; q22) | AML(成人)与 t (16;16) (p13; q22) | AML(成人)与 t (8; 21) (q22; q22) | 继发性 AML(成人) | 未经治疗的 AML(成人)美国
-
Merck Sharp & Dohme LLC终止DLBCL | AML,包括新发 AML 和继发于 MDS 的 AML
-
Ciceri FabioAssociazione Italiana per la Ricerca sul Cancro; Gruppo Italiano Trapianto di Midollo Osseo招聘中
-
The First Affiliated Hospital of Soochow University招聘中
-
The First Affiliated Hospital of Soochow UniversitySecond Affiliated Hospital of Soochow University; The Second People's Hospital of Huai'an; The... 和其他合作者未知
-
GWT-TUD GmbH完全的
-
Essen Biotech尚未招聘
-
Assiut UniversitySouth Egypt Cancer Institute完全的
-
University Hospital Inselspital, Berne终止
-
Maximilian Stahl, MDSyndax Pharmaceuticals尚未招聘
-
The University of Hong Kong完全的
-
Elucida OncologyTherapeutic Advances in Childhood Leukemia and Lymphoma (TACL)撤销急性髓性白血病 | 反洗钱,童年 | 复发性小儿 AML | 难治性小儿 AML
-
Daiichi Sankyo, Inc.完全的反洗钱美国, 大韩民国, 台湾, 英国, 法国, 澳大利亚, 西班牙, 意大利, 加拿大, 新加坡, 德国, 荷兰, 香港, 比利时, 克罗地亚, 捷克语, 匈牙利, 波兰, 塞尔维亚
-
Zhejiang UniversityHangzhou Qihanjiyin Biotech Co.,Ltd.招聘中
-
Therapeutic Advances in Childhood Leukemia ConsortiumBristol-Myers Squibb主动,不招人
-
Weill Medical College of Cornell UniversityPfizer; Jazz Pharmaceuticals终止
-
Washington University School of MedicineThe Leukemia and Lymphoma Society; Rising Tide Foundation; St. Louis Children's Hospital Foundation招聘中
-
Institut de Recherches Internationales Servier完全的
-
Bio-Path Holdings, Inc.完全的复发性成人急性髓性白血病 | 急性淋巴细胞白血病 | 骨髓增生异常综合症 | Ph1 阳性 CML美国
-
French Innovative Leukemia OrganisationAcute Leukemia French Association招聘中反洗钱,成人 | 复发的成人 AML | 难治性急性髓细胞白血病 | FLT3-TKD突变 | FLT3-ITD法国